NielsenIQ and Sephora team to provide the full view of beauty market
New deal democratizes access to data for beauty brands across U.S. and Canada.
New deal democratizes access to data for beauty brands across U.S. and Canada.
GLP-1 medications have emerged as a breakthrough treatment, with prescriptions growing 38 percent annually between 2022 and 2024 and sales expected to reach $100 billion by 2030.
New research from Shoppers Drug Mart's charitable arm reveals sizeable gaps in education, awareness for common menstrual health conditions.
Health-conscious consumers globally are reshaping retail, demanding transparency, ethical production, and tech solutions for proactive well-being.
The findings reflect broader industry pressures, as plans respond to rising expectations around cost transparency, digital access and personalized service.
Findings reveal the need for more robust identity verification practices.
The 2024 Sustainable Market Share Index shows CPG products marketed with sustainable attributes increased market share by 2.6 percentage points since last year, but are dwarfed by European markets.
With U.S. consumer interest in plant-based wellness showing no signs of slowing, pharmacy retailers are well-positioned to tap into this expanding market.
Airsupra demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone.
The performance generation is redefining what it means to hydrate. It’s no longer just about quenching thirst—it’s about fueling the body with intention.
Fragrance maintains its position as the top-performing category.
Retail and foodservice have never been measured this holistically
A new BSM Media survey finds that U.S. families fear potential price increases and availability issues when planning holiday gift buying amid tariff uncertainty.
Marketing leaders must adapt strategies to address economic challenges and inflation concerns.
In one of the largest and longest real-world obesity studies to date, Embla tracked nearly 2,700 adults over 64 weeks and achieved 16.7% average weight loss using 66% less semaglutide than typical U.S. doses.
New research by RSR, sponsored by Jumpmind, finds 65% of retailers say their current store technology can’t support the modern shopping experience consumers crave.